Cannabis Sativa L
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Cannabis – a Complex and Rapidly Evolving Landscape
CANNABIS – A COMPLEX AND RAPIDLY EVOLVING LANDSCAPE Abstract ABOUT THE AUTHOR The humble Cannabis sativa plant, cultivated for millennia for its psychoactive properties and more, is today considered one of the most controversial and complex plants in the world. Starting in the early to mid-20th century, much of its use became recreational, but by the early 1970s discoveries began to emerge around its potential medical efficacies. This article will discuss current knowledge of how cannabis engages with the brain and the endocannabinoid system (ECS) and provide an overview of the new market landscapes brought about by changes in governing laws Dr. Georgiana Willwerth-Pascutiu and regulations, which are affecting usage by our current and potential [email protected] customers. It will also explore the additional hazards, concerns, and Georgiana Willwerth-Pascutiu is Vice President, Global Medical Director considerations of cannabis use in countries where it remains illegal. at RGA. She is board certified in Insurance Medicine by the American Introduction Academy of Insurance Medicine (AAIM) and specialized in internal medicine, Naturally occurring psychoactive substances have been part of human life nephrology and ultrasonography. for millennia. One of the most frequently utilized plant sources of these Dr. Willwerth-Pascutiu is also a past substances, Cannabis sativa, is also the best-known worldwide. For the president of the Canadian Life Insurance Medical Officers Association (CLIMOA) past half-century, scientific and medical interest in its many compounds, and currently chairs its scientific known as cannabinoids, has been increasing. Today, the two best-known, committee. She is a frequent presenter and has contributed several articles to delta-9 tetrahydrocannabinol (THC), its psychoactive chemical, and insurance industry publications. -
Medical Cannabis Cultivation Center Application Illinois Department of Agriculture Springfield, Illinois
Medical Cannabis Cultivation Center Application Illinois Department of Agriculture Springfield, Illinois Schedule 1 – Suitability of the Proposed Facility The following Measures are found in Section 1000.110(b)(1) of the rules: Measure 1: The applicant must demonstrate that the proposed facility is suitable for effective and safe cultivation of medical cannabis, is sufficient in size, power allocation, air exchange and air flow, interior layout, lighting, and sufficient both in the interior and exterior to handle the bulk agricultural production of medical cannabis, cannabis-infused products, product handling, storage, trimming, packaging, loading and shipping. The loading/unloading of medical cannabis in the transport motor vehicle for shipping shall be in an enclosed, secure area out of public sight. Measure 2: The applicant must demonstrate the ability to continue to meet qualifying patient demand by expanding the cultivation facility in a quick and efficient manner with minimal impact on the environment and the surrounding community. Measure 3: The applicant provides an employee handbook that will provide employees with a working guide to the understanding of the day-to-day administration of personnel policies and practices. The following outline is meant as a guide for the applicant to follow in submitting information to meet the above Measures. It is not an all-inclusive list or description of required information. It is the applicant's responsibility to demonstrate compliance with the rules and application instructions. Any engineering drawings, flow diagrams, and descriptions must be adequate to illustrate your plans. 1. Location Area Map (1000.40(e), 1000.100(d)(19), 1000.220(a)) Provide a location map of the area surrounding the facility. -
Targeting the Endocannabinoid System to Reduce Nociception
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2011 Targeting the endocannabinoid system to reduce nociception Lamont Booker Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medical Pharmacology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2419 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Targeting the Endocannabinoid System to Reduce Nociception A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. By Lamont Booker Bachelor’s of Science, Fayetteville State University 2003 Master’s of Toxicology, North Carolina State University 2005 Director: Dr. Aron H. Lichtman, Professor, Pharmacology & Toxicology Virginia Commonwealth University Richmond, Virginia April 2011 Acknowledgements The author wishes to thank several people. I like to thank my advisor Dr. Aron Lichtman for taking a chance and allowing me to work under his guidance. He has been a great influence not only with project and research direction, but as an excellent example of what a mentor should be (always willing to listen, understanding the needs of each student/technician, and willing to provide a hand when available). Additionally, I like to thank all of my committee members (Drs. Galya Abdrakmanova, Francine Cabral, Sandra Welch, Mike Grotewiel) for your patience and willingness to participate as a member. Our term together has truly been memorable! I owe a special thanks to Sheryol Cox, and Dr. -
A Review on Cannabis Sativa: Its Compounds and Their Effects
Int. J. Pharm. Sci. Rev. Res., 53(2), November - December 2018; Article No. 12, Pages: 59-63 ISSN 0976 – 044X Review Article A Review on Cannabis sativa: Its Compounds and Their Effects Ranju Rajput, *Dr. Krishan Kumar Department of Food and Biotechnology, Jayoti Vidyapeeth Women’s University, Jaipur, Rajasthan, India. *Corresponding author’s E-mail: [email protected] Received: 01-11-2018; Revised: 25-11-2018; Accepted: 10-12-2018. ABSTRACT Our society often considered the use of cannabis is an under-reported activity. Cannabis is used to relieve neuropathic and chronic pain. Cannabis, produced from the Cannabis sativa plant, have been used in three forms: herbal cannabis, the dried leaves and flowering tops The resin of the cannabis is the pressed secretions of the plant, known as ‘hashish’ or ‘charash. Cannabis sativa is an herbaceous species originated from Central Asia. It has been used in medicine and as a source of textile fiber since ancient times. The cannabis sativa is a fast growing plant attracted the people’s interest because of its multi-purpose applications. It is a rich source of photochemical, cellulose and woody fibers. The more interest is also due to its metabolites which show potent bioactivities on human health. In this review, the phytochemicals is discussed by putting a special emphasis on molecules including cannabinoids, terpenes and phenolic compounds. Cannabinoids are represented as the most studied group of compounds, because of their wide range of pharmaceutical effects in humans, including psychotropic activities. This article aims to update the current knowledge and evidence of using cannabis and its derivatives with a view to the sociolegal context and perspectives for future research. -
Williamstown Cannabis Cultivation Business Plan
Williamstown Cannabis Cultivation Business Plan Davis Collison and Rosa Kirk-Davidoff We are on the stolen land of the Stockbridge-Munsee Band of the Mohican. “The legal marijuana industry has the potential to save local farms and repair a broken food system.”- Suehiko Ono, EOS Farms Introduction Averill Cook Davis and Rosa ● Who we are ● Environmental Planning ○ Senior Seminar for Environmental Studies Majors ● This project - Williamstown Cannabis Cultivation ● Questions: Best scale to start? Opportunities for a craft market? Jake Zieminski Our Clients ● Averill H Cook ○ Born and raised in Williamstown. ○ BS degree from University of Vermont ○ Owned and operated a pellet manufacturing business for 12 years ○ Traveled throughout numerous countries consulting in wood energy ○ Maintained an operated Wendling Farm in Williamstown where he grew up ○ Superior land stewardship has been paramount throughout his career Averill Cook Jake Zieminski Our Clients ● Jake Zieminski ○ Born and raised in Cheshire Ma on family dairy farm. Lived in Boston for 20 years and recently moved family back in 2018 to launch cannabis start-up. ○ Cannabis Entrepreneur ■ Current owner of CAVU Hemp, Cheshire Ma- MDAR licensed 2019 ■ 2021- CCC – Marijuana Cultivation Applicant ■ Cannabis Activist, Educator and Advisor since 2014 ○ Prior to transitioning into Cannabis industry in 2018, Mr. Zieminski was a management consultant focused in healthcare. Mr. Zieminski has spent the primary part of his career in client based performance improvement roles at PricewaterhouseCoopers(PwC), -
Cannabinoid As Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity
Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity Sudipta Baroi1, Achintya Saha2, Ritesh Bachar3 and Sitesh C Bachar4 1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Dhaka Dhaka-1000, Bangladesh 2Department of Chemical Technology, Pharmaceutical & Fine Chemical Technology Division University of Calcutta, India 3Department of Pharmacy, School of Science and Engineering, University of Information Technology and Sciences (UITS), Dhaka-1212, Bangladesh 4Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh (Received: April 15, 2020; Accepted: June 2, 2020; Published (web): June 28, 2020) ABSTRACT: Inhibition of aromatase (CYTP450), a key enzyme in the estrogen biosynthesis, could result in regression of estrogen-dependent tumors and even prevent the promotion of breast cancer. The present research has been designed for searching a potent chemical moiety from natural sources to inhibit aromatase enzyme, the over- functionality of which causes the breast cancer. Cannabis sativa contains a very much promising group of cannabinoids with more than 66 compounds with reported anticancer property and for the search of a target specific potent aromatase inhibitor, 61 cannabinoids from C. sativa were selected. The Structures Data File (SDF) of these ligand molecules were subjected to docking studies at the binding site of aromatase X-ray crystallographic structure based on lower resolution of the protein crystal structure and higher docking accuracy, predicted by calculating the correlation between experimental activities and Glide dock scores and compared with the standard aromatase ligand androstenedione and aromatase inhibitor fadrozole with existing drug for breast cancer treatment. The best docked pose of each ligand was selected on the basis of the highest dock score related to the binding free energies of the internal dataset compounds as compared to their observed activities. -
Gold Rush to Green Rush: Cannabis Cultivation on Yurok Tribal Lands
From Gold Rush to Green Rush: Cannabis Cultivation on Yurok Tribal Lands Kaitlin Reed Ph.D. Candidate, Native American Studies, University of California, Davis Charles Eastman Fellow of Native American Studies, Dartmouth College “The New World is in fact a very old world.” Anderson, M. Kat. Tending the Wild: Native American Knowledge and the Management of California's Natural Resources. Berkeley: University of California Press, 2005. 2019 North American Cannabis Summit 2 California Indians “Pre Contact”: over 1 million 1769: ~500,000 Native people living in California 1900: Less than 20,000 2019 North American Cannabis Summit 3 3 Waves of California Genocide Spanish Missionization (1769-1820) Mexican-American War (1821-1845) Gold Rush/Formation of California (1846- 1873) 2019 North American Cannabis Summit 4 2019 North American Cannabis Summit 5 Environmental Impacts of Gold Mining . Food depletion . Impacts to water quantity/quality . Mercury contamination . Destruction of other natural resources, e.g. timber 2019 North American Cannabis Summit 6 Yurok Tribal Lands 2019 North American Cannabis Summit 7 2019 North American Cannabis Summit 8 Gold Rush Green Rush 1. Land Dispossession 2. Indian Removal 3. Cultural Sovereignty 4. Ecological Colonialism 5. Impacts to Water 6. Impacts to Wildlife 7. Prioritization of Profit 8. Generational Impacts 2019 North American Cannabis Summit 9 Rush Mentality The Rush mentality is what founded Humboldt County… people act like that was so long ago and we have just definitely moved on and we’re just this very green friendly place, we’re liberals, we’re leftist. This is how people think of Humboldt County but what founded us is this Gold Rush and we have been rushing ever since, and so after the Gold Rush ‘well, gold didn’t make us enough money, let’s rush any kind of minerals that we can get’ and then after that you have ‘well that didn’t make us enough, let’s rush timber’ and then after – you know what I mean? … And I think we’ve been rushing since 1849. -
1496 Amending Cannabis Zoning Regulations (PDF)
ORDINANCE NO. 1496 AN ORDINANCE OF THE CITY COUNCIL OF THE CITY OF ARCATA AMENDING ZONING REGULATIONS PERTAINING TO CANNABIS REGULATION The City Council of the City of Arcata does hereby ordain as follows: Section 1. Amendment to Table 1-1 – Zoning Districts: The Zoning Districts as shown in Table 1-1 of Title IX, Planning and Zoning, Chapter 1, Planning and Zoning Standards, Section 9000, Land Use Code, Article 1, Land Use Code Applicability, Section 9.12.020 Zoning Map and Zoning Districts, are hereby amended to replace the words “Medical Marijuana” with “Cannabis” and revise the “:MMIZ” zoning district symbol with “CIZ” as shown in the following strike through and bold double underscore text (unchanged text within the Table is omitted and is shown by “* * *”): Table 1-1 – Zoning Districts Zoning District General Plan Designation Symbol Name of Zoning District Implemented by Zoning District * * * Combining Zones :CD Creamery District Industrial - Limited :HL Historic Landmark All :MMCIZ Medical Marijuana Cannabis Innovation Zone Specific Industrial – Limited and Industrial – General properties - See Section 9.28.130, Figure 2-25. * * * Section 2. Amendment to Allowable Land Uses; Table 2-1. The Allowable Land Uses for the Agricultural and Resource Zoning Districts depicted in Table 2-1 of Title IX, Planning and Zoning, Chapter 1, Planning and Zoning Standards, Section 9000, Land Use Code, Article 2, Zoning Uses, Section 9.22.030 Agricultural and Resource Zoning District Allowable Land Uses, are hereby amended to replace the words “Medical -
15.04.610.270 - Marijuana/Cannabis Commercial Uses
15.04.610.270 - Marijuana/Cannabis Commercial Uses. Commercial Cannabis activities, including but not limited to cultivation, manufacturing, testing, distribution, and retail are subject to the standards and procedures of the Municipal Code, State Law, and the regulations set forth in these Zoning Regulations. A. Applicability. These standards apply to all establishments that are involved in any commercial cannabis activity. B. Definitions1 []. The following words or phrases, whenever used in this section, have the following definitions: 1. A-license. A State license issued for cannabis or cannabis products that are intended for adults 21 years of age and over and who do not possess physician's recommendations. 2. Attending Physician. An individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California or the Osteopathic Medical Board of California and who has taken responsibility for an aspect of the medical care, treatment, diagnosis, counseling, or referral of a patient and who has conducted a medical examination of that patient before recording in the patient's medical record the physician's assessment of whether the patient has a serious medical condition and whether the medical use of cannabis is appropriate. 3. Bureau of Cannabis Control ("the Bureau"). The bureau within the California Department of Consumer Affairs created to develop, administer and enforce comprehensive rules for medicinal and adult-use cannabis in California. The Bureau is responsible for the regulation and licensing of all commercial cannabis retail, distribution, testing, microbusinesses and temporary cannabis events in California. 4. California Department of Food and Agriculture — CalCannabis Cultivation Licensing ("the CDFA"). -
What Is Delta-8 THC?? Cannabinoid Chemistry 101
What is Delta-8 THC?? Cannabinoid Chemistry 101 National Conference on Weights and Measures Annual Meeting - Rochester, NY Matthew D. Curran, Ph.D. July 21, 2021 Disclaimer Just to be clear… • I am a chemist and not a lawyer so: • This presentation will not discuss the legal aspects of Δ8-THC or DEA’s current position. • This presentation will not discuss whether Δ8-THC is considered “synthetic” or “naturally occurring.” • This is not a position statement on any issues before the NCWM. • Lastly, this should only be considered a scientific sharing exercise. Florida Department of Agriculture and Consumer Services 2 Cannabis in Florida Cannabis Syllabus • What is Cannabis? • “Mother” Cannabinoid • Decarboxylation • Relationship between CBD and THC • What does “Total” mean? • Dry Weight vs. Wet Weight • What does “Delta-9” mean? • Relationship between “Delta-8” and “Delta-9” • CBD to Delta-8 THC • Cannabinoid Chemistry 202… Florida Department of Agriculture and Consumer Services 3 Cannabis Cannabis • Cannabis sativa is the taxonomic name for the plant. • The concentration of Total Δ9-Tetrahydrocannabinol (Total Δ9-THC) is critical when considering the varieties of Cannabis sativa. • Hemp – (Total Δ9-THC) 0.3% or less • Not really a controversial term, “hemp” • Marijuana/cannabis – (Total Δ9-THC) Greater than 0.3% • Controversial term, “marijuana” • Some states prohibit the use of this term whereas some states have it in their laws. • Some states use the term “cannabis.” • Not italicized • Lower case “c” Florida Department of Agriculture and -
Roles of Cannabidiol in Reversing Proteinopathies
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 21 May 2020 doi:10.20944/preprints202005.0340.v1 Review Roles of Cannabidiol in Reversing Proteinopathies Raju Dash1, Md. Chayan Ali2†, Israt Jahan3†, Yeasmin Akter Munni1†, Sarmistha Mitra4, Md. Abdul Hannan1,5, Binod Timalsina1, Diyah Fatimah Oktaviani1, Ho Jin Choi1, Il Soo Moon1* 1Department of Anatomy, Dongguk University College of Medicine, Gyeongju 38066, Republic of Korea 2Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia 7003, Bangladesh 3Department of Pharmacy, Faculty of Life and Earth Sciences, Jagannath University, Dhaka 1100, Bangladesh. 4Plasma Bioscience Research Center and Department of Plasma Bio display, Kwangwoon University, Seoul 01897, Republic of Korea 5Department of Biochemistry and Molecular Biology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh †These authors have contributed equally. *Corresponding author: Il Soo Moon Mailing address: Department of Anatomy, Dongguk University College of Medicine, 123 Dongdae-ro, Gyeongju 38066, Republic of Korea Phone: +82-54-770-2414 Fax: +82-54-770-2447 Email: [email protected] Abstract: Cannabidiol is a well-known non-psychotropic phytocannabinoid from Cannabis sativa, which exerts a broad range of neuropharmacological activities in the central nervous systems. Over the past years, compelling evidence from preclinical and clinical studies support therapeutic potentials of cannabidiol in various neurological disorders, including neurodegenerative diseases. Neurodegenerative diseases are characterized by the accumulation of misfolded or aggregated protein due to the defective protein homeostasis or proteostasis network, termed as proteinopathies. Because of its role in the protein homeostasis network, cannabidiol could be a potent molecule to revert not only age-associated neurodegeneration but also other protein misfolding disorders. -
In Silico Assessment of Drug-Like Properties of Phytocannabinoids in Cannabis Sativa
EDUCATUM JSMT Vol. 4 No. 2 (2017) ISSN 2289-7070 / eISSN 2462-2451 (1-7) https://ejournal.upsi.edu.my/journal/EDSC In Silico Assessment of Drug-Like Properties of Phytocannabinoids in Cannabis Sativa Shakinaz Desa1*, Asiah Osman2, and Richard Hyslop3 1Department of Biology, Universiti Pendidikan Sultan Idris, Malaysia, 2Natural Product Division, Forest Research Institute Malaysia, 3Department of Chemistry and Biochemistry, University of Northern Colorado, USA *Corresponding author: [email protected] Abstract This study investigated drug-like properties of phytocannabinoids in Cannabis sativa using an in silico study. We report sixteen phytocannabinoids: cannabidiol (CBD), cannabidiolic acid (CBDA), cannabinol (CBN), cannabichromene (CBC), cannabigerol (CBG), cannabicyclol (CBL), cannabivarin (CBV), cannabidivarin (CBDV), cannabichromevarin (CBCV), cannabigerovarin (CBGV), cannabinodiol (CBDL), cannabielsoin (CBE), cannabitriol (CBT), Δ9-tetrahydrocannabinol (Δ9-THC), Δ9-tetrahydrocannabivarin (Δ9-THCV), and Δ8-tetrahydrocannabinol (Δ8-THC). All chemical structures and properties were obtained from PubChem Compound, National Center for Biotechnology Information, U.S. National Library of Medicine. Molinspiration was used for the calculation of molecular properties and bioactivity score. The parameters were molecular weight (MW), number of hydrogen acceptor (HBA), number of hydrogen donor (HBD), partition coefficient (cLogP), polar surface area (PSA) and number of rotatable bonds (NROTB). We predicted bioactivity scores for G Protein-Coupled Receptors (GPCR) ligand, ion channel modulator, kinase inhibitor, nuclear receptor ligand, protease inhibitor and enzyme inhibitor. Lipinski’s rule was used as reference to determine the drug-like properties of the phytocannabinoids. All compounds have MW<500, HBA<10, HBD<5, TPSA<140Å2 and NRTOB<10. Bioactivity score showed an active or moderately active in all compounds.